Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

KW-5139 effective for reducing gastric stasis following pancreatoduodenectomy

Sep. 10, 1998

FDA grants fast track status for CDP-571

Sep. 10, 1998

Allelix GI drug moves into the clinic

Sep. 10, 1998

Positive clinical trial results reported for HTF-919

Sep. 7, 1998

FDA clears Intron A for pediatric chronic hepatitis B

Sep. 4, 1998

Novel agents for irritable bowel syndrome in early development at Kyorin

Sep. 1, 1998

Chugai investigates macrolide compounds as prokinetic agents

Sep. 1, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

Rebetron receives priority review status

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...